Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Lartigau

Showing results (11-20 of 116) with videos related to

Pageof 12
Sort By:
Current Opinion in Otolaryngology & Head and Neck Surgery|January 18, 2012
Evidence based and new developments in re-irradiation for recurrent or second primary head and neck cancersRaphaëlle Mouttet-Audouard, Louis Gras, Bénédicte Comet, et al.
The Lancet. Oncology|July 4, 2012
Focal HIFU for prostate cancerGilles Créhange, David Azria, Eric Lartigau, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 4, 2009
Chemosensitivity of radioresistant cells in the multicellular spheroids of A549 lung adenocarcinomaDegang Shi, Genming Shi, Gang Huang, et al.
Frontiers in Endocrinology|September 20, 2021
Hypoxia in Solid Tumors: How Low Oxygenation Impacts the "Six Rs" of RadiotherapyAndria Rakotomalala, Alexandre Escande, Alessandro Furlan, et al.
Archives of Dermatology|December 17, 2003
Radiotherapy alone for primary Merkel cell carcinomaLaurent Mortier, Xavier Mirabel, Charles Fournier, et al.
Radiation Oncology (London, England)|October 17, 2014
GTV-based prescription in SBRT for lung lesions using advanced dose calculation algorithmsThomas Lacornerie, Albert Lisbona, Xavier Mirabel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 21, 2010
Which α/β ratio and half-time of repair are useful for predicting outcomes in prostate cancer?Philippe Nickers, Johanne Hermesse, Jean-Marie Deneufbourg, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|January 14, 2014
Extracranial stereotactic body radiotherapy. Review of main SBRT features and indications in primary tumorsCarmen Rubio, Rosa Morera, Ovidio Hernando, et al.
BMC Cancer|May 18, 2018
BioPro-RCMI-1505 trial: multicenter study evaluating the use of a biodegradable balloon for the treatment of intermediate risk prostate cancer by intensity modulated radiotherapy; study protocolDavid Pasquier, Emilie Bogart, François Bonodeau, et al.
Onkologie|April 18, 2009
Extracranial stereotactic radiotherapy: preliminary results with the CyberKnifeEric Lartigau, Xavier Mirabel, Bernard Prevost, et al.
Pageof 12

Showing results (11-20 of 116) with videos related to

Sort By:
Pageof 12
Current Opinion in Otolaryngology & Head and Neck Surgery|January 18, 2012
Evidence based and new developments in re-irradiation for recurrent or second primary head and neck cancersRaphaëlle Mouttet-Audouard, Louis Gras, Bénédicte Comet, et al.
The Lancet. Oncology|July 4, 2012
Focal HIFU for prostate cancerGilles Créhange, David Azria, Eric Lartigau, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 4, 2009
Chemosensitivity of radioresistant cells in the multicellular spheroids of A549 lung adenocarcinomaDegang Shi, Genming Shi, Gang Huang, et al.
Frontiers in Endocrinology|September 20, 2021
Hypoxia in Solid Tumors: How Low Oxygenation Impacts the "Six Rs" of RadiotherapyAndria Rakotomalala, Alexandre Escande, Alessandro Furlan, et al.
Archives of Dermatology|December 17, 2003
Radiotherapy alone for primary Merkel cell carcinomaLaurent Mortier, Xavier Mirabel, Charles Fournier, et al.
Radiation Oncology (London, England)|October 17, 2014
GTV-based prescription in SBRT for lung lesions using advanced dose calculation algorithmsThomas Lacornerie, Albert Lisbona, Xavier Mirabel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 21, 2010
Which α/β ratio and half-time of repair are useful for predicting outcomes in prostate cancer?Philippe Nickers, Johanne Hermesse, Jean-Marie Deneufbourg, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|January 14, 2014
Extracranial stereotactic body radiotherapy. Review of main SBRT features and indications in primary tumorsCarmen Rubio, Rosa Morera, Ovidio Hernando, et al.
BMC Cancer|May 18, 2018
BioPro-RCMI-1505 trial: multicenter study evaluating the use of a biodegradable balloon for the treatment of intermediate risk prostate cancer by intensity modulated radiotherapy; study protocolDavid Pasquier, Emilie Bogart, François Bonodeau, et al.
Onkologie|April 18, 2009
Extracranial stereotactic radiotherapy: preliminary results with the CyberKnifeEric Lartigau, Xavier Mirabel, Bernard Prevost, et al.
Pageof 12